Nivolumab plus ipilimumab versus nivolumab in individuals with treatment-naive programmed death-ligand 1 positive metastatic soft tissue sarcomas: a multicentre retrospective study

BACKGROUND: Currently, the choice of treatment for individuals with metastatic soft tissue sarcomas (MSTS) presents a significant challenge to clinicians. The aim of this retrospective study was to assess the efficacy and safety of nivolumab plus ipilimumab (NPI) versus nivolumab alone (NIV) in indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yaolin, Liu, Xiangzhen, Liu, Jijun, Liang, Donghua, Zhao, Mingdong, Yu, Weiguang, Chen, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856818/
https://www.ncbi.nlm.nih.gov/pubmed/33530966
http://dx.doi.org/10.1186/s12885-021-07843-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856818/
https://www.ncbi.nlm.nih.gov/pubmed/33530966
http://dx.doi.org/10.1186/s12885-021-07843-3

Ejemplares similares